Salus, a healthcare technology company focused on medication safety, today announced the enterprise deployment of its Medication Administration Protection System (MAPS) within Houston Methodist, a ...
Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and platforms, today debuted the IV Verify Line Labeling System, an automated solution, at the 2026 American ...
Weight loss drugs, like Ozempic, Zepbound and other GLP-1 medications, continue to grow in popularity across Connecticut and ...
There are three key ways to reduce the administrative burden in the US health care system.
This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, ...
Lilly says Foundayo was approved to treat obesity and can lead to long-term weight loss, alongside diet and exercise.
Federal regulators have approved the GLP-1 tablet Foundayo for weight loss. The once-daily oral pill provides an alternative ...
The data confirms a broader trend of surging diagnoses for mental illness, autism and ADHD, which is driving up NDIS costs and piling the pressure on Labor.
Migraine Again on MSN
‘Playing chicken’ with your pain? Why medication underuse makes migraine worse
Learn about medication underuse headache (MUH), why taking your acute migraine meds early is key, and expert strategies for ...
Humans have long dreamed of a cure-all.Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. In Greek mythology, the goddess Panacea carried a ...
As geopolitics bring reshoring interest to a fever pitch, the United States Pharmacopeia (USP) is adding to the impetus for ...
Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results